Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Pretax Margin %: -148.92% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Singapore Institute Of Advanced Medicine Holdings Pretax Margin %?

Singapore Institute Of Advanced Medicine Holdings SGX:9G2 +3.45% Pretax Margin % is -148.92% as of Mar. 2026. The stock has 2 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Singapore Institute Of Advanced Medicine Holdings ranks worse than 92.92% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Singapore Institute Of Advanced Medicine Holdings's Pre-Tax Income for the three months ended in Mar. 2026 was S$-5.67 Mil. Singapore Institute Of Advanced Medicine Holdings's Revenue for the three months ended in Mar. 2026 was S$3.81 Mil. Therefore, Singapore Institute Of Advanced Medicine Holdings's pretax margin for the quarter that ended in Mar. 2026 was -148.92%.

The historical rank and industry rank for Singapore Institute Of Advanced Medicine Holdings's Pretax Margin % or its related term are showing as below:

SGX:9G2' s Pretax Margin % Range Over the Past 10 Years
Min: -224.91   Med: -116.82   Max: -72.66
Current: -184.24


SGX:9G2's Pretax Margin % is ranked worse than
92.92% of 664 companies
in the Healthcare Providers & Services industry
Industry Median: 4.255 vs SGX:9G2: -184.24

Singapore Institute Of Advanced Medicine Holdings  (SGX:9G2) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Singapore Institute Of Advanced Medicine Holdings Pretax Margin % Related Terms


Singapore Institute Of Advanced Medicine Holdings Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Singapore Institute Of Advanced Medicine Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singapore Institute Of Advanced Medicine Holdings Pretax Margin % Chart

Singapore Institute Of Advanced Medicine Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Pretax Margin %
-72.66 -104.85 -116.82 -224.91 -172.18

Singapore Institute Of Advanced Medicine Holdings Quarterly Data
Jun21 Jun22 Jun23 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only 0.00 -157.13 -220.33 0.00 -148.92

SGX:9G2 vs HCA, THC, DVA: Pretax Margin % Comparison

For the Medical Care Facilities subindustry, Singapore Institute Of Advanced Medicine Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Singapore Institute Of Advanced Medicine Holdings Pretax Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singapore Institute Of Advanced Medicine Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Singapore Institute Of Advanced Medicine Holdings's Pretax Margin % falls into.



Singapore Institute Of Advanced Medicine Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Singapore Institute Of Advanced Medicine Holdings's Pretax Margin for the fiscal year that ended in Jun. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-27.047/15.709
=-172.18 %

Singapore Institute Of Advanced Medicine Holdings's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-5.668/3.806
=-148.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -148.92% mean?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a Pretax Margin % of -148.92% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. According to the industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #617 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 92.9%.
Is Singapore Institute Of Advanced Medicine Holdings' Pretax Margin % too high?
Singapore Institute Of Advanced Medicine Holdings' current Pretax Margin % is -148.92%. Based on the distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #617 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Singapore Institute Of Advanced Medicine Holdings' Pretax Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #617 out of 664 companies for Pretax Margin %. This places Singapore Institute Of Advanced Medicine Holdings in the lower half of its industry. The industry median Pretax Margin % is 4.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.26, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singapore Institute Of Advanced Medicine Holdings's current Pretax Margin % is -148.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Institute Of Advanced Medicine Holdings stock overvalued right now?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a current Pretax Margin % of -148.92%. The current Pretax Margin % is -148.92%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Singapore Institute Of Advanced Medicine Holdings (SGX:9G2), the current Pretax Margin % is -148.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Singapore Institute Of Advanced Medicine Holdings Business Description

Address 1 Biopolis Drive, No. 02-01 Amnios, Singapore, SGP, 138622
Singapore Institute of Advanced Medicine Holdings Ltd is a Singapore-based healthcare service provider comprising a medical center, diagnostic imaging facility, nuclear medicine clinic, and radiation oncology service providing proton and X-ray radiotherapy. Its operating segments are: Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services, and Investment Holding. Medical Diagnostics and Treatments include: cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services. Radiation Therapy encompasses proton beam therapy, photon radiation therapy, and Medical oncology. The majority of the company's revenue comes from the Medical Diagnostics and Treatments segment.